| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Santosh V Suryavanshi, Mariia Zaiachuk, Nazar Pryimak, Igor Kovalchuk, Olga Kovalchu. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro. Cells. vol 11. issue 9. 2022-05-14. PMID:35563697. |
cannabinoids, mainly cannabidiol (cbd) and Δ |
2022-05-14 |
2023-08-13 |
Not clear |
| Geoffrey A Dubrow, Rahul S Pawar, Cynthia Srigley, Jennifer Fong Sam, Christian Talavera, Christine H Parker, Gregory O Noona. A survey of cannabinoids and toxic elements in hemp-derived products from the United States marketplace. Journal of food composition and analysis : an official publication of the United Nations University, International Network of Food Data Systems. vol 97. 2022-05-13. PMID:35547641. |
herein, 11 cannabinoids were quantified using liquid chromatography with diode-array detection in a non-representative sampling of 147 products labeled as containing hemp or cannabidiol. |
2022-05-13 |
2023-08-13 |
Not clear |
| Bradley H Lee, Alexandra Sideris, Karim S Ladha, Rebecca L Johnson, Christopher L W. Cannabis and Cannabinoids in the Perioperative Period. Anesthesia and analgesia. 2022-05-13. PMID:35551150. |
cannabis and cannabinoids in the perioperative period. |
2022-05-13 |
2023-08-13 |
Not clear |
| Taylor R Ewell, Kieran S S Abbotts, Hannah M Butterklee, Matthew C Bomar, Christopher Bel. Acute Cannabidiol Administration Does Not Increase the Thermic Effect of Feeding in Men with Overweight and Obesity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 36 Suppl 1. 2022-05-13. PMID:35551845. |
the influence of cannabidiol, a non-psychoactive component of cannabis sativa l., on the thermogenic properties of the endocannabinoid system in humans is unclear. |
2022-05-13 |
2023-08-13 |
Not clear |
| Joshua L Rein, Ken Mackie, Thomas R Kleyman, Lisa M Satli. Localization and Functional Characterization of the Cannabinoid Receptor Type 1 (CB1R) in the Kidney. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 36 Suppl 1. 2022-05-13. PMID:35555645. |
cannabis and synthetic cannabinoid consumption is increasing worldwide. |
2022-05-13 |
2023-08-13 |
human |
| Romola Cavet, Juliet Sostena, Albert Huang, Paul Hauser, Luke D. Effects of Cannabidiol in a Caenorhabditis Elegans Amyotrophic Lateral Sclerosis Model. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 36 Suppl 1. 2022-05-13. PMID:35555765. |
cannabidiol, the second most prevalent cannabinoid in the cannabis sativa plant, is a potential therapeutic tool for als due to its antioxidant, anti-inflammatory, and anti-spasticity effects, as well as its complementary role in treating other neurodegenerative diseases. |
2022-05-13 |
2023-08-13 |
caenorhabditis_elegans |
| Victoria L Vernail, Sarah S Bingaman, Wesley M Raup-Konsavage, Kent E Vrana, Amy C Arnol. Acute Cannabigerol Administration Lowers Blood Pressure in Mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 36 Suppl 1. 2022-05-13. PMID:35555999. |
cannabigerol (cbg) is a cannabinoid compound that is synthesized from cannabis sativa l. and acts as a substrate for both Δ9-tetraydrocannabinol (Δ9-thc) and cannabidiol (cbd) formation. |
2022-05-13 |
2023-08-13 |
mouse |
| Christopher Y Chin, Katiana Ron, Alyssa Fernandez, Ram Kandasam. The Effects of ß-caryophyllene on Pain-Evoked and Pain-Depressed Behaviors in Rats with Chronic Inflammatory Pain. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 36 Suppl 1. 2022-05-13. PMID:35556755. |
the antinociceptive effects of major cannabinoids such as ∆9-tetrahydrocannabinol (thc) and cannabidiol (cbd) have been extensively studied in rats. |
2022-05-13 |
2023-08-13 |
human |
| Lawrence M Carey, David R Maguire, Charles P Franc. Effects of cannabidiol (CBD), ∆ FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 36 Suppl 1. 2022-05-13. PMID:35560573. |
effects of cannabidiol (cbd), ∆ the use of cannabinoids as adjuvants to opioid therapies to mitigate the problematic side effects of opioids or to decrease the doses of opioids necessary to relieve pain is an area of intense interest. |
2022-05-13 |
2023-08-13 |
monkey |
| Thomas P Sakma. Getting to the heart of cannabis health risks. Cell. vol 185. issue 10. 2022-05-13. PMID:35561662. |
show that the increased cardiovascular risks associated with cannabis use are mediated by proinflammatory cannabinoid 1 (cb1) receptor signaling, which can be ameliorated with the natural antioxidant agent genistein. |
2022-05-13 |
2023-08-13 |
Not clear |
| Isobel Lavender, Iain S McGregor, Anastasia Suraev, Ronald R Grunstein, Camilla M Hoyo. Cannabinoids, insomnia, and other sleep disorders. Chest. 2022-05-10. PMID:35537535. |
sleep disturbances are often cited as a primary reason for medicinal cannabis use and there is increasing clinical interest in the therapeutic potential of cannabinoids in treating sleep disorders. |
2022-05-10 |
2023-08-13 |
Not clear |
| Isobel Lavender, Iain S McGregor, Anastasia Suraev, Ronald R Grunstein, Camilla M Hoyo. Cannabinoids, insomnia, and other sleep disorders. Chest. 2022-05-10. PMID:35537535. |
this critical review summarises the current evidence for the use of cannabinoids as a treatment for sleep disorders, and provides an overview of endocannabinoid modulation of sleep-wake cycles, and the sleep-modulating effects of plant-derived cannabinoids such as Δ⁹-tetrahydrocannabinol (thc), cannabidiol (cbd), and cannabinol (cbn). |
2022-05-10 |
2023-08-13 |
Not clear |
| Isobel Lavender, Iain S McGregor, Anastasia Suraev, Ronald R Grunstein, Camilla M Hoyo. Cannabinoids, insomnia, and other sleep disorders. Chest. 2022-05-10. PMID:35537535. |
while current interest in, and uptake of, medicinal cannabis use for sleep disorders may have surpassed the evidence-base, there is a strong rationale for continued investigation into the therapeutic potential of cannabinoids. |
2022-05-10 |
2023-08-13 |
Not clear |
| Yuma T Ortiz, Lance R McMahon, Jenny L Wilkerso. Medicinal Cannabis and Central Nervous System Disorders. Frontiers in pharmacology. vol 13. 2022-05-09. PMID:35529444. |
cannabinoids, including those found in cannabis, have shown promise as potential therapeutics for numerous health issues, including pathological pain and diseases that produce an impact on neurological processing and function. |
2022-05-09 |
2023-08-13 |
Not clear |
| Jennifer Laborada, Philip R Cohe. Cutaneous Squamous Cell Carcinoma and Lichen Simplex Chronicus Successfully Treated with Topical Cannabinoid Oil: A Case Report and Summary of Cannabinoids in Dermatology. Cureus. vol 14. issue 4. 2022-05-09. PMID:35530920. |
cannabidiol is a member of the cannabinoids, consisting of a diverse class of compounds derived from |
2022-05-09 |
2023-08-13 |
Not clear |
| Ignacio Badiola, Amit Doshi, Samer Narouz. Cannabis, cannabinoids, and cannabis-based medicines: future research directions for analgesia. Regional anesthesia and pain medicine. 2022-05-09. PMID:35534020. |
cannabis, cannabinoids, and cannabis-based medicines: future research directions for analgesia. |
2022-05-09 |
2023-08-13 |
human |
| Roberta Risoluti, Giuseppina Gullifa, Alfredo Battistini, Stefano Materazz. Development of a "single-click" analytical platform for the detection of cannabinoids in hemp seed oil. RSC advances. vol 10. issue 71. 2022-05-06. PMID:35519692. |
the novelty of this completely automated tool consists of a miniaturized nir spectrometer operating in a wireless mode that permits processing samples in a rapid and accurate way and to obtain in a single click the early detection of a residual amount of cannabinoids in oil, including cannabidiol (cbd), the psychoactive Δ9-tetrahydrocannabinol (thc) and the Δ9-tetrahydrocannabinolic acid (thca). |
2022-05-06 |
2023-08-13 |
Not clear |
| Graziella Filippini, Silvia Minozzi, Francesca Borrelli, Michela Cinquini, Kerry Dwa. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis. The Cochrane database of systematic reviews. vol 5. 2022-05-05. PMID:35510826. |
cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis. |
2022-05-05 |
2023-08-13 |
Not clear |
| Farzaneh Darigh, Alireza Iranbakhsh, Zahra Oraghi Ardebili, Mostafa Ebad. Non-thermal plasma improved callogenesis performance and elicited the production of cannabinoids by modifying DNA methylome, expression of WRKY1 and ERF1B transcription factors, and expression of genes that contributed to the biosynthesis of cannabinoids. Protoplasma. 2022-05-03. PMID:35503387. |
this study intends to validate whether cold plasma contributes to improving callogenesis performance and eliciting the production of cannabinoids in cannabis. |
2022-05-03 |
2023-08-13 |
Not clear |
| Farzaneh Darigh, Alireza Iranbakhsh, Zahra Oraghi Ardebili, Mostafa Ebad. Non-thermal plasma improved callogenesis performance and elicited the production of cannabinoids by modifying DNA methylome, expression of WRKY1 and ERF1B transcription factors, and expression of genes that contributed to the biosynthesis of cannabinoids. Protoplasma. 2022-05-03. PMID:35503387. |
the hplc assessment proved the high potency of cold plasma to enhance the synthesis of cannabinoids, including cannabigerol (cbg), cannabidiol (cbd), and cannabinol (cbn). |
2022-05-03 |
2023-08-13 |
Not clear |